1. Inicio
  2. Proyectos y Estudios
  3. A Phase I/II study of Brigatinib in pediatric and young adult patients with ALK+ Anaplastic Large Cell Lymphoma,Inflammatory Myofibroblastic Tumors or other solid tumors.

A Phase I/II study of Brigatinib in pediatric and young adult patients with ALK+ Anaplastic Large Cell Lymphoma,Inflammatory Myofibroblastic Tumors or other solid tumors.

Datos básicos

ENSAYO CLÍNICO ITCC-098 2021-002713-34 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2023

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

PRINCESS MÁXIMA CENTER FOR PEDIATRIC ONCOLOGY B.V.,

Cita

Compartir